Voloridge Investment Management’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.88M Sell
57,555
-21,397
-27% -$1.3M 0.02% 581
2026
Q1
$4.38M Sell
78,952
-150,185
-66% -$8.08M 0.02% 699
2025
Q4
$11.1M Buy
229,137
+219,816
+2,358% +$8.57M 0.04% 554
2025
Q3
$285K Buy
+9,321
New +$214K ﹤0.01% 1129
2025
Q2
Sell
-30,873
Closed -$574K 1151
2025
Q1
$574K Sell
30,873
-56,640
-65% -$945K ﹤0.01% 1091
2024
Q4
$1.16M Sell
87,513
-85,708
-49% -$2.08M ﹤0.01% 1022
2024
Q3
$5.8M Buy
+173,221
New +$5.92M 0.02% 742
2021
Q3
Sell
-44,975
Closed -$1.17M 1624
2021
Q2
$1.17M Sell
44,975
-3,996
-8% -$95.8K 0.01% 1201
2021
Q1
$1.05M Buy
48,971
+29,421
+150% +$743K 0.01% 1006
2020
Q4
$420K Sell
19,550
-44,487
-69% -$1.08M ﹤0.01% 1155
2020
Q3
$945K Sell
64,037
-38,485
-38% -$694K 0.01% 954
2020
Q2
$2.29M Sell
102,522
-39,995
-28% -$731K 0.03% 576
2020
Q1
$2.01M Buy
142,517
+86,589
+155% +$1.31M 0.06% 345
2019
Q4
$909K Buy
55,928
+22,257
+66% +$526K 0.02% 677
2019
Q3
$1.18M Buy
+33,671
New +$1.6M 0.02% 594
2018
Q1
Sell
-5,224
Closed -$526K 487
2017
Q4
$526K Buy
+5,224
New +$385K 0.01% 417

Other funds holding ANAB

Voloridge Investment Management's ANAB Position: Q2 2026 in Review

Voloridge Investment Management reduced its AnaptysBio (ANAB) stake by 27% in Q2 2026, selling an estimated $1.3M and leaving 57,555 shares worth $3.88M. The position accounts for 0.02% of the portfolio, ranked #581.

Voloridge Investment Management first reported a position in ANAB in Q4 2017 and has held it in 16 quarters since. The position peaked at $11.1M in Q4 2025. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • Voloridge Investment Management held 57,555 shares of AnaptysBio worth $3.88M as of Q2 2026.
  • Voloridge Investment Management sold 21,397 AnaptysBio shares in Q2 2026, an estimated $1.3M.
  • AnaptysBio made up 0.02% of Voloridge Investment Management's portfolio in Q2 2026, its #581 holding.
  • Voloridge Investment Management first reported a position in AnaptysBio in Q4 2017 and has held it in 16 quarters since.
  • Voloridge Investment Management's AnaptysBio position peaked at $11.1M in Q4 2025.
  • 213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on Voloridge Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.